Y-Mabs Therapeutics Inc (NASDAQ: YMAB)’s Stock Is Up 325.52% Since The Beginning Of The Year, Likely To Sustain The Trend In 2024
During the last session, Y-Mabs Therapeutics Inc (NASDAQ:YMAB)’s traded shares were 0.3 million, with the beta value of the company hitting 0.75. At the end